...
首页> 外文期刊>Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology >Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II
【24h】

Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II

机译:心脏再同步治疗起搏器或心脏再同步治疗除颤器:什么决定了选择的选择? - 来自ESC CRT调查II的选择

获取原文
获取原文并翻译 | 示例

摘要

Aims The decision to implant a cardiac resynchronization therapy pacemaker (CRT-P) or a cardiac resynchronization therapy defibrillator (CRT-D) may be challenging. There are no clear guideline recommendations as no randomized study of cardiac resynchronization therapy (CRT) has been designed to compare the effects of CRT-P with those of CRT-D on patients' outcomes. In the CRT Survey II, we studied patient and implantation centre characteristics associated with the choice of CRT-P vs. CRT-D.
机译:旨在植入心脏重新同步治疗起搏器(CRT-P)或心脏重新同步治疗除颤器(CRT-D)的决定可能是挑战性的。 没有明确的准则建议,因为没有对心脏重新同步治疗(CRT)的随机研究旨在将CRT-P与CRT-D关于患者结果的影响进行比较。 在CRT调查II中,我们研究了与CRT-P的选择相关的患者和植入中心特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号